ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANGEL PEREZ MD

Internal Medicine

21,750

$1.14M

712
502 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

RICARDO ADAMES M.D.

Internal Medicine

21,543

$1.19M

723
583 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

WILLIAM SURBER M. D.

Internal Medicine

21,526

$988K

638
521 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$46
Average prescription price

Avg: $67

CHARITY ABREU-LAWRENCE M.D.

Internal Medicine

21,404

$1.7M

788
670 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $67

HENRY GRAINGER DO

Internal Medicine

21,306

$1.51M

834
517 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

37%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $67

GENE BIGHAM M.D.

Internal Medicine

21,282

$1.2M

544
464 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

28%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

JOSE PORRAS MD

Internal Medicine

21,269

$1.49M

761
636 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

NORMA RIVERA-OPIO M.D.

Internal Medicine

21,044

$1.47M

988
773 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $67

VLADIMIR GREBENNIKOV M.D.

Internal Medicine

20,961

$1.9M

493
403 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$91
Average prescription price

Avg: $67

LUIS SCHAEFFER M.D.

Internal Medicine

20,684

$959K

567
386 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

37%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$46
Average prescription price

Avg: $67

RICHARD LOCK M.D.

Internal Medicine

20,654

$1.08M

803
657 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $67

SHYLESH GANTA M.D.

Internal Medicine

20,594

$1.24M

853
766 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $67

SASPIN OMAR MD

Internal Medicine

20,553

$898K

862
765 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$44
Average prescription price

Avg: $67

JORGE GUEVARA MD

Internal Medicine

20,542

$1.35M

863
689 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 27%

$66
Average prescription price

Avg: $67

RANDY FUENTES M.D.

Internal Medicine

20,386

$1.04M

857
635 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

LUKE HINSHAW MD

Internal Medicine

20,208

$1.19M

741
540 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

SUBRAMANIAM JAGADEESAN MD

Internal Medicine

20,116

$1.63M

781
607 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$81
Average prescription price

Avg: $67

LISA PHAM M.D.

Internal Medicine

19,984

$3,123

310
290 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$0
Average prescription price

Avg: $67

ROBERT KELLER MD

Internal Medicine

19,937

$1.17M

820
585 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

ADEBOLA OLATUNJI M.D.

Internal Medicine

19,898

$1.11M

498
294 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

41%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

SERGIO LARA MD

Internal Medicine

19,887

$828K

685
588 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$42
Average prescription price

Avg: $67

E. HUDMAN M.D.

Internal Medicine

19,863

$1.3M

793
582 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $67

SUDHEER KARNATI MD

Internal Medicine

19,818

$903K

591
498 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$46
Average prescription price

Avg: $67

SHALINI KATIKANENI MD

Internal Medicine

19,774

$1.21M

393
316 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

JAMES TRAN MD

Internal Medicine

19,768

$1.07M

927
708 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank